Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Coleman, RL; Fleming, GF; Brady, MF; Swisher, EM; Steffensen, KD; Friedlander, M; Okamoto, A; Moore, KN; Ben-Baruch, NE; Werner, TL; Cloven, NG; Oaknin, A; DiSilvestro, PA; Morgan, MA; Nam, JH; Leath, CA; Nicum, S; Hagemann, AR; Littell, RD; Cella, D

Coleman, RL (reprint author), Univ Texas MD Anderson Canc Ctr, 1155 Pressler Dr, Houston, TX 77030 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (25): 2403

Abstract

BACKGROUND Data are limited regarding the use of poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors, such as veliparib, in combination wit......

Full Text Link